{"id":2723,"date":"2023-01-16T15:48:02","date_gmt":"2023-01-16T20:48:02","guid":{"rendered":"https:\/\/fifarma.org\/?post_type=publicaciones&#038;p=2723"},"modified":"2025-06-18T17:42:05","modified_gmt":"2025-06-18T22:42:05","slug":"sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica","status":"publish","type":"publicaciones","link":"https:\/\/fifarma.org\/pt\/publicacoes\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\/","title":{"rendered":"Sostenibilidad de la Salud en Am\u00e9rica Latina y el papel de la Industria Farmac\u00e9utica"},"content":{"rendered":"\n<p>El logro de la cobertura universal de salud (CUS) se ha convertido en una prioridad para los gobiernos de Am\u00e9rica Latina (AL), pero aumentar la cobertura inevitablemente conlleva el incremento de los costos de salud y el desaf\u00edo para fomentar la eficiencia<\/p>\n\n\n\n<div class=\"wp-block-file\"><a id=\"wp-block-file--media-0c73d53c-5b81-439c-b210-194e3f93b088\" href=\"https:\/\/fifarma.org\/wp-content\/uploads\/2023\/01\/FIFARMA-Healthcare-Sustainability-Working-Document-20190903-STC-Spanish.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Previsualizar<\/a><\/div>\n\n\n<div class=\"taxonomy-idioma wp-block-post-terms\"><a href=\"https:\/\/fifarma.org\/pt\/idioma\/espanol\/\" rel=\"tag\">Espa\u00f1ol<\/a><\/div>\n\n<div class=\"taxonomy-ano wp-block-post-terms\"><a href=\"https:\/\/fifarma.org\/pt\/ano\/2019\/\" rel=\"tag\">2019<\/a><\/div>\n\n<div class=\"taxonomy-etiquetas-publicacion wp-block-post-terms\"><a href=\"https:\/\/fifarma.org\/pt\/etiquetas-publicacoes\/a-saude-como-investimento\/\" rel=\"tag\">Salud como inversi\u00f3n<\/a><\/div>\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div> \n","protected":false},"author":24,"parent":0,"template":"","ano":[46],"idioma":[31],"etiquetas-publicacion":[38],"categoria-publicacion":[29],"class_list":["post-2723","publicaciones","type-publicaciones","status-publish","hentry","ano-46","idioma-espanol","etiquetas-publicacion-salud-como-inversion","categoria-publicacion-reporte"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.7 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Sostenibilidad de la Salud en Am\u00e9rica Latina y el papel de la Industria Farmac\u00e9utica - FIFARMA<\/title>\n<meta name=\"description\" content=\"El logro de la cobertura universal de salud (CUS) se ha convertido en una prioridad para los gobiernos de Am\u00e9rica Latina (AL), pero aumentar la cobertura inevitablemente conlleva el incremento de los costos de salud y el desaf\u00edo para fomentar la eficiencia\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/pt\/publicacoes\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sostenibilidad de la Salud en Am\u00e9rica Latina y el papel de la Industria Farmac\u00e9utica\" \/>\n<meta property=\"og:description\" content=\"El logro de la cobertura universal de salud (CUS) se ha convertido en una prioridad para los gobiernos de Am\u00e9rica Latina (AL), pero aumentar la cobertura inevitablemente conlleva el incremento de los costos de salud y el desaf\u00edo para fomentar la eficiencia\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/pt\/publicacoes\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-18T22:42:05+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\\\/\",\"name\":\"Sostenibilidad de la Salud en Am\u00e9rica Latina y el papel de la Industria Farmac\u00e9utica - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"datePublished\":\"2023-01-16T20:48:02+00:00\",\"dateModified\":\"2025-06-18T22:42:05+00:00\",\"description\":\"El logro de la cobertura universal de salud (CUS) se ha convertido en una prioridad para los gobiernos de Am\u00e9rica Latina (AL), pero aumentar la cobertura inevitablemente conlleva el incremento de los costos de salud y el desaf\u00edo para fomentar la eficiencia\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publicaciones\",\"item\":\"https:\\\/\\\/fifarma.org\\\/publicaciones\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Sostenibilidad de la Salud en Am\u00e9rica Latina y el papel de la Industria Farmac\u00e9utica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sostenibilidad de la Salud en Am\u00e9rica Latina y el papel de la Industria Farmac\u00e9utica - FIFARMA","description":"El logro de la cobertura universal de salud (CUS) se ha convertido en una prioridad para los gobiernos de Am\u00e9rica Latina (AL), pero aumentar la cobertura inevitablemente conlleva el incremento de los costos de salud y el desaf\u00edo para fomentar la eficiencia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/pt\/publicacoes\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\/","og_locale":"pt_BR","og_type":"article","og_title":"Sostenibilidad de la Salud en Am\u00e9rica Latina y el papel de la Industria Farmac\u00e9utica","og_description":"El logro de la cobertura universal de salud (CUS) se ha convertido en una prioridad para los gobiernos de Am\u00e9rica Latina (AL), pero aumentar la cobertura inevitablemente conlleva el incremento de los costos de salud y el desaf\u00edo para fomentar la eficiencia","og_url":"https:\/\/fifarma.org\/pt\/publicacoes\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\/","og_site_name":"FIFARMA","article_modified_time":"2025-06-18T22:42:05+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fifarma.org\/publicaciones\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\/","url":"https:\/\/fifarma.org\/publicaciones\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\/","name":"Sostenibilidad de la Salud en Am\u00e9rica Latina y el papel de la Industria Farmac\u00e9utica - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"datePublished":"2023-01-16T20:48:02+00:00","dateModified":"2025-06-18T22:42:05+00:00","description":"El logro de la cobertura universal de salud (CUS) se ha convertido en una prioridad para los gobiernos de Am\u00e9rica Latina (AL), pero aumentar la cobertura inevitablemente conlleva el incremento de los costos de salud y el desaf\u00edo para fomentar la eficiencia","breadcrumb":{"@id":"https:\/\/fifarma.org\/publicaciones\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/publicaciones\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/publicaciones\/sostenibilidad-de-la-salud-en-america-latina-y-el-papel-de-la-industria-farmaceutica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"Publicaciones","item":"https:\/\/fifarma.org\/publicaciones\/"},{"@type":"ListItem","position":3,"name":"Sostenibilidad de la Salud en Am\u00e9rica Latina y el papel de la Industria Farmac\u00e9utica"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones\/2723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/publicaciones"}],"about":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/types\/publicaciones"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media?parent=2723"}],"wp:term":[{"taxonomy":"ano","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/ano?post=2723"},{"taxonomy":"idioma","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/idioma?post=2723"},{"taxonomy":"etiquetas-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/etiquetas-publicacion?post=2723"},{"taxonomy":"categoria-publicacion","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/categoria-publicacion?post=2723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}